Biotech & Health
Williams·
Japan Marks Regenerative Medicine Milestone: World's First iPSC-Based Treatment Approved for Commercial Use
Japan has granted the first-ever regulatory approval for a medical product based on induced pluripotent stem cells (iPSCs), a breakthrough technology pioneered 20 years ago. This milestone marks the shift of regenerative medicine from the lab to commercial healthcare, offering new hope for spinal cord and nerve repair.
Williams·